Showing results (81-90 of 1,142) with videos related to
Sort By:
Pageof 115
JHEP Reports : Innovation in Hepatology|March 10, 2020
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolismSander Lefere, Frank TackeCancers|February 13, 2021
Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular CarcinomaMoritz Peiseler, Frank TackeClinical and Experimental Gastroenterology|September 13, 2014
Interleukins in chronic liver disease: lessons learned from experimental mouse modelsLinda Hammerich, Frank TackeCellular & Molecular Immunology|February 25, 2016
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategiesCynthia Ju, Frank TackeExpert Opinion on Investigational Drugs|June 28, 2023
Efruxifermin, an investigational treatment for fibrotic or cirrhotic nonalcoholic steatohepatitis (NASH)Tobias Puengel, Frank TackeDigestive Diseases (Basel, Switzerland)|May 13, 2016
Liver Fibrosis: From Pathogenesis to Novel TherapiesRalf Weiskirchen, Frank TackeInnere Medizin (Heidelberg, Germany)|September 2, 2022
[The gut-liver axis: how the gut promotes liver disease]Münevver Demir, Frank TackeExpert Opinion on Drug Discovery|June 12, 2020
How effective are nonalcoholic fatty liver disease models for drug discovery?Jana Hundertmark, Frank TackeInternational Journal of Molecular Sciences|July 24, 2021
Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical RelevanceSiyer Roohani, Frank TackePageof 115